CC BY-NC-ND 4.0 · Endosc Int Open 2023; 11(08): E778-E784
DOI: 10.1055/a-2117-8444
Original article

Initial multicenter experience using a novel articulating through-the-scope traction device for endoscopic submucosal dissection

Maham Hayat
1   Center for Interventional Endoscopy, AdventHealth Orlando, Orlando, United States (Ringgold ID: RIN440172)
,
Alexander Schlachterman
2   Division of Gastroenterology, Hepatology & Nutrition, University of Florida, Gainesville, United States (Ringgold ID: RIN3463)
,
Grace Schiavone
3   Internal Medicine, Thomas Jefferson University Hospital, Philadelphia, United States (Ringgold ID: RIN23217)
,
Meir Mizrahi
4   Gastroenterology, Florida Center for Gastroenterology, Key Largo, United States
,
Jong Kyu Park
5   Gastroenterology, Mayo Clinic in Florida, Jacksonville, United States (Ringgold ID: RIN156400)
,
Vivek Kumbhari
5   Gastroenterology, Mayo Clinic in Florida, Jacksonville, United States (Ringgold ID: RIN156400)
,
Antonio Cheesman
6   Gastroenterology, SLU, Saint Louis, United States (Ringgold ID: RIN7547)
,
Peter V Draganov
7   Medicine/Gastroenterology, University of Florida, Gainesville, United States
,
Muhammad Khalid Hasan
8   Center for Interventional Endoscopy, Florida Hospital Orlando, Orlando, United States (Ringgold ID: RIN6244)
,
Dennis Yang
1   Center for Interventional Endoscopy, AdventHealth Orlando, Orlando, United States (Ringgold ID: RIN440172)
› Author Affiliations

Abstract

Background and study aims A single-operator, articulating, through-the-scope (TTS) traction device was recently developed to facilitate endoscopic submucosal dissection (ESD). Clinical data on the performance of this device are limited. We report an initial multicenter experience with ESD using this articulating TTS traction device.

Patients and methods Retrospective analysis on all consecutive patients who underwent ESD using this traction device (T-ESD) at five centers between August 2021 and December 2022. Endpoints included: rates of en-bloc resection, R0 resection, curative resection, and adverse events.

Results Thirty-six patients (median age 64.8 years; 47.2% women) underwent ESD (median lesion size 40 mm; interquartile range [IRQ]: 27.5–67.5) for lesions in the esophagus (n=2), stomach (n=8), sigmoid colon (n=6), and rectum (n=20). Submucosal fibrosis was encountered in one-third of the lesions (33.3%). Median ESD time was 104.6 minutes (IQR: 65–122). En-bloc, R0 and curative resection were achieved in 94.4%, 91.6%, and 97.2%, respectively. The single patient with non-curative resection of an invasive rectal adenocarcinoma underwent surgery. There were no cases of delayed bleeding or perforation. There was no recurrence on surveillance endoscopy (n=20) at a median of 6 months (IQR: 3.75–6).

Conclusions This initial multicenter experience demonstrates high resection rates and excellent safety profile when performing ESD with this novel articulating TTS device. Dynamic real-time traction may lower the technical difficulty of ESD. Additional studies are needed to assess its cost-effectiveness and compare its usefulness with other traction devices and techniques during ESD.



Publication History

Received: 13 April 2023

Accepted after revision: 20 June 2023

Accepted Manuscript online:
26 June 2023

Article published online:
16 August 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany